Trials / Completed
CompletedNCT04840082
Optimal Length for Nasal Mid-turbinate and Nasopharyngeal Swabs
Optimal Insertion Length for Nasal Mid-turbinate and Nasopharyngeal Swabs for Respiratory Virus Infection Diagnostic Testing - a Clinical Trial
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 109 (actual)
- Sponsor
- Rigshospitalet, Denmark · Academic / Other
- Sex
- All
- Age
- 16 Years
- Healthy volunteers
- Accepted
Summary
This study aim to explore the optimal swap insertion length for mid-turbinate and nasopharyngeal samples. Our clinical trial took place at a Covid-19 test center in Copenhagen. Participants consisted of voluntary citizens who were at the test center for a nasopharyngeal antigen quicktest. An endoscopic examination was performed simultaneous with the swap to measure the length from the vestibulum nasi to the posterior wall of the nasopharynx and the mid-turbinate.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | Nasopharyngeal swab for COVID-19 testing | A nasopharyngeal swab was performed endoscopically video guided to measure the actual length from to the mid turbinate and the posterior nasopharyngeal wall |
Timeline
- Start date
- 2021-03-07
- Primary completion
- 2021-03-08
- Completion
- 2021-03-08
- First posted
- 2021-04-09
- Last updated
- 2021-04-09
Locations
1 site across 1 country: Denmark
Source: ClinicalTrials.gov record NCT04840082. Inclusion in this directory is not an endorsement.